The Skinny on Weight Loss Drugs
Double Take By Newton - Un pódcast de Newton Investment Management North America LLC - Miercoles
Categorías:
As the obesity epidemic rages across the globe, new weight loss drugs have become so popular that some manufacturers are unable to meet patient demand. Dr. David Katz, founder and CEO of Diet ID, joins Double Take to discuss investment ramifications of these hotly demanded medications.
